News

Medscape13h
What Drives Elexacaftor-Tezacaftor-Ivacaftor Use After Cystic Fibrosis Lung Transplant in the US?
About a third of lung transplant patients with cystic fibrosis receive elexacaftor-tezacaftor-ivacaftor; use is higher among ...
Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis
Vertex Pharmaceuticals today announced that Health Canada has granted Marketing Authorization for PrALYFTREKTM (vanzacaftor/tezacaftor/deutivacaftor), a new triple combination therapy for patients ...
WPBF Channel 25 on MSN1d
‘On the Record’: Combating cystic fibrosis
‘On the Record’: Combating cystic fibrosis ...
‘Life-changing’ therapy now available for cystic fibrosis patients
The new pill is seen as a ‘major leap forward’ for hundreds of patients living with the rarest forms of cystic fibrosis ...
People with cystic fibrosis to get life-changing new once-a-day pill
It said that 95% of people with cystic fibrosis in England will now be eligible for modulator therapy. The new drug, also ...
NHS England8d
NHS to roll-out new ‘triple combination’ therapy for hundreds of children and adults with cystic fibrosis
NHS England » NHS to roll-out new ‘triple combination’ therapy for hundreds of children and adults with cystic fibrosis ...
Cystic Fibrosis Foundation6d
Cystic Fibrosis Foundation Commits Up to an Additional $24 Million for Prime Medicine to Develop Gene Editing Therapy
Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million in Prime Medicine to continue ...
pharmaphorum7d
New cystic fibrosis triple from Vertex backed for NHS use
Reimbursement authority NICE has backed routine NHS use of Vertex's once-daily triple therapy Alyftrek ...
Nursing Times6d
NICE fast-tracking of new cystic fibrosis drug marks ‘positive step’
NHS patients in England with cystic fibrosis will be among the first in Europe to access a new treatment for their condition, ...
EU Commission Approves Vertex Pharmaceutical’s (VRTX) Cystic Fibrosis Treatment
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of Goldman Sachs’ top healthcare stock picks. On July 1, the ...
Diagnosed with Cystic Fibrosis as a Child, She Was Told She’d Never See 30. Now She’s a Mom of Twins (Exclusive)
At 7 years old, Morgan Barrett was diagnosed with cystic fibrosis. Prior to her diagnosis, she struggled to gain weight ...